CAS: 1518-61-2; 3,4-Dihydroxybutanoic Acid

该化合物是一种有机化合物,其特点是四碳丁酸脊椎有2个氢氧(-OH)组,该化合物无色,晶状固体,由于能形成氢结体,在水中溶解;它具有酸性和酒精功能性,在各种化学反应中成为多用途分子;氢氧基化合物的存在有助于其再活动,使其能够参与进化和氧化反应. 3,4-二氢氧丁酸是生物化学研究感兴趣的,可能用于合成药品和食品添加剂,其分子结构允许它与生物系统互动,有可能影响代谢途径.此外,必须小心处理这一化合物,如同任何化学物质一样,以确保安全和遵守有关条例.

结构式图片

相似化合物

3068-00-6 42890-76-6 617-55-0

上下游产品

but-3-enoic acid ethanol 2-iodo-1,3-propanediol sodium cyanide 4-Hydroxy-dihydro-furan-2-on 2-buten-4-olide malic acid (S)-Malic acid

合成工艺路线路线简述

    📜乙烯基乙酸置于alkaline Potassium Permanganate体系中,化学反应生成3,4-二羟基丁酸
    参考文献:Glattfeld; Miller,Journal Of The American Chemical Society,1920,Vol. 42,P. 2315
    标题:Glattfeld; Miller,Journal Of The American Chemical Society,1920,Vol. 42,P. 2315

    海关参考信息

    专利信息


    专利号:US-4870199-A
    优先权日:1986-04-30
    标题 :Processes for the synthesis of diprotected R[R*,S*]-3,5-dihydroxy-6-oxohexanoate esters
    发明人:CHEN KAU-MING; HARDTMANN GOETZ E; KAPA PRASAD K; LEE GEORGE T; LINDER JEROME; WATTANASIN SOMPONG
    权利人:SANDOZ PHARMACEUTICALS CORP
    摘要:Process for the synthesis of compounds of the formula in R[R*,S*] enantiomeric form, wherein each P1 is independently an hydroxy group-protecting group, and R2z is C1-4alkyl, benzyl or allyl, comprising, as a key step when R2z is R2x, the reaction of the compound of the formula in (S) enantiomeric form with a compound of the formula Mg &cir& +2 ((-)OOC-CH2-COOR2x)2 to obtain a compound of the formula in (S) enantiomeric form, and, as a key step when R2z is R2y, the reaction of a compound of the formula in (S) enantioimeric form with a compound of the formula Li(+)(-)CH2-COOR2y to obtain a compound of the formula in (S) enantiomeric form, wherein R2x is primary or secondary C1-4alkyl, benzyl or allyl, R2y is C1-4alkyl not containing an asymmetric carbon atom, and R3' is methyl or ethyl, processes for the synthesis of compounds of the formula comprising reacting a compound of the formula with the reaction product of a strong base and a compound of the formula optionally followed by, when R2z is allyl, cleavage of the allyl and P1 groups to obtain the corresponding compound of the formula wherein each R7 is methyl or ethyl, R is as defined in the specification, and each P1 independently and R2z are as defined above, and the compounds of the formula wherein R and each R7 are as defined above.

    专利号:US-9809566-B2
    优先权日:2012-09-06
    标题:Organocatalytic process for asymmetric synthesis of decanolides
    发明人:RAWAT VARUN; DEY SOUMEN; SHELKE ANIL MARUTI; SURYAVANSHI GURUNATH MALLAPPA; SUDALAI ARUMUGAM
    权利人:COUNCIL SCIENT IND RES
    摘要:The present invention discloses organocatalytic process for asymmetric synthesis of highly enantioselective decanolide compounds in high yield with >99% ee. Further, the present invention disclose cost effective, improved organocatalytic process for asymmetric synthesis of highly enantioselective decanolides compounds from non-chiral, cheap, easily available raw materials.

    专利号:EP-2589587-A1
    优先权日:2011-11-04
    标题:Synthesis of nitrogen substituted cyclopropanes
    发明人:RASPARINI MARCELLO; TADDEI MAURIZIO; CINI ELENA; MINELLI COSIMA; TURNER NICHOLAS; HUGENTOBLER KATHARINA GLORIA
    权利人:CHEMO IBERICA SA
    摘要:The invention is about a new synthetic pathway for the preparation of enantiomerically pure nitrogen substituted cyclopropanes, in particular the trans- cyclopropanamine ( 1 ), a key intermediate in the synthesis of Ticagrelor:n n The invention also relates to the processes for preparing said compounds or their salts and the use of said compounds as intermediates in preparing pharmaceutically active ingredients.

    专利号:US-2010159540-A1
    优先权日:2007-03-26
    标题:Synthesis of resolvins and intermediates, compounds prepared thereby, and uses thereof
    发明人:RODRIGUEZ ANA; SPUR BERND
    权利人:RODRIGUEZ ANA; SPUR BERND
    摘要:Methods are disclosed for the preparation of a new class of lipid mediators known as resolvins, with Resolvin D6 (4,17-dihydroxy-5E,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid) being exemplary. Also disclosed are methods for the efficient synthesis of key intermediates in the preparation of such resolvins, such as isotopically labeled ω-3 fatty acid metabolites, and derivatives and analogs thereof. The invention likewise extends to the intermediates so prepared, and to the resolvins prepared with their use.

    专利号:WO-0172706-A1
    优先权日:2000-03-28
    标题 :Synthesis of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
    发明人:SAMBASIVAN GANESH; SRIDHARAN MADHAVAN; PADUDEVASTANA SATHYASHANKER; POORNAPRAJNA ACHARYA; MATHEW JOY; SRINATH SUMITHRA; NAIR SATHEESH
    权利人:BIOCON LTD; SAMBASIVAN GANESH; SRIDHARAN MADHAVAN; PADUDEVASTANA SATHYASHANKER; POORNAPRAJNA ACHARYA; MATHEW JOY; SRINATH SUMITHRA; NAIR SATHEESH
    摘要:The present invention discusses a novel process for the synthesis of [R-(R*,R*)]-2-(4-fluorophenyl)-B,D-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt by using 4-fluoro-α-[2-methyl-1-oxopropyl]η-oxo-N-β-diphenylbenzene butaneamide with (4R)-methyl 6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-3-acetate. The compound so prepared is useful as inhibitors of the enzyme HMG-CoA reductase and are thus used as hypolipidemic and hypocholesterolemic agents.

    专利号:US-2023151394-A1
    优先权日:2020-03-31
    标题 :Biologic synthesis of diols from amino acids
    发明人:ZENG AN-PING; LIU YONGFEI
    权利人:TAIZHOU SIMPLU TECH CO LTD
    摘要:A method for the enzymatically catalyzed synthesis of a diol from an amino acid includes enzymatically hydroxylating the amino acid, enzymatically deaminating the amino acid, the deamination resulting in the formation of an oxo group at the position of the amino group, enzymatically decarboxylating the amino acid, and enzymatically hydrogenating the oxo group resulting from the deamination reaction.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1208/s12248-020-00543-z
    摘要:Felmlee MA, Morse BL, Morris ME. γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology. The AAPS Journal. 2021 Jan 08;23(1):22. doi: 10.1208/s12248-020-00543-z.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知